Literature DB >> 20032397

IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.

Xiaoying Zhang1, Peiji Yin, Dongmei DI, Guanghua Luo, Lu Zheng, Jiang Wei, Jun Zhang, Yuanping Shi, Jichen Zhang, Ning Xu.   

Abstract

We previously reported that matrix metalloproteinase (MMP)-10 mRNA levels were significantly lower in tumor tissues than in adjacent normal tissues in human non-small cell lung cancer (NSCLC), whereas protein levels of MMP-10 were higher in the tumor tissues than the adjacent tissues. The mechanism of this divergence is still unknown. In the present study the role of Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) on interleukin (IL)-6 mediated regulation of MMP-10 expression was investigated in a human lung adenocarcinoma cell line (A549 cells) and the molecular regulatory mechanism of MMP-10 expression was explored. A549 cells were stimulated by different concentrations of IL-6 with or without AG490, a specific JAK2 inhibitor. It was demonstrated that IL-6 moderately reduced the MMP-10 mRNA levels, whereas it significantly enhanced the MMP-10 protein mass in the A549 cells. This phenomenon mimicked the divergence of mRNA level and protein mass of MMP-10 in human NSCLC. Moreover, the present study indicated that IL-6 regulation of MMP-10 expression was via the JAK2/STAT3 pathway. STAT3 mRNA levels were significantly increased when the cells were treated with IL-6, whereas when AG490 (50 muM) was added to the cell cultures, IL-6-induced increase of STAT3 mRNA levels was abolished. Meanwhile, AG490 blocked the IL-6-induced inhibition of MMP-10 mRNA as well as blocking the IL-6-induced increase of MMP-10 protein mass in the A549 cells. Neither IL-6 nor AG490 influenced JAK2 mRNA levels in the A549 cell cultures. It is concluded that the JAK2/STAT3 pathway is involved in the IL-6-mediated regulation of MMP-10, and IL-6 can moderately reduce MMP-10 mRNA levels and strongly increase MMP-10 protein mass in human lung adenocarcinoma A549 cells. Contrasting effects of IL-6 on MMP-10 mRNA level and protein concentration in A549 cells may partially explain the divergence of MMP-10 mRNA level and protein mass in human NSCLC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032397

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  20 in total

1.  Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6.

Authors:  Zhongyang Lu; Yanchun Li; Junfei Jin; Xiaoming Zhang; Maria F Lopes-Virella; Yan Huang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-17       Impact factor: 8.311

2.  MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53.

Authors:  Imayavaramban Lakshmanan; Shereen Salfity; Parthasarathy Seshacharyulu; Satyanarayana Rachagani; Abigail Thomas; Srustidhar Das; Prabin D Majhi; Rama Krishna Nimmakayala; Raghupathy Vengoji; Subodh M Lele; Moorthy P Ponnusamy; Surinder K Batra; Apar Kishor Ganti
Journal:  Clin Cancer Res       Date:  2017-02-14       Impact factor: 12.531

3.  IL-6 polymorphism in non-small cell lung cancer: a prognostic value?

Authors:  Mónica Gomes; Ana Coelho; António Araújo; Andreia Azevedo; Ana Luísa Teixeira; Raquel Catarino; Rui Medeiros
Journal:  Tumour Biol       Date:  2015-01-09

4.  Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium.

Authors:  Dana N Mitzel; Richard J Jaramillo; Heather Stout-Delgado; Albert P Senft; Kevin S Harrod
Journal:  J Gen Virol       Date:  2013-10-10       Impact factor: 3.891

5.  Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.

Authors:  Paul Zarogoulidis; Lonny Yarmus; Kaid Darwiche; Robert Walter; Haidong Huang; Zhigang Li; Bojan Zaric; Kosmas Tsakiridis; Konstantinos Zarogoulidis
Journal:  Immunome Res       Date:  2013-08-12

6.  The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms.

Authors:  Zhen Lu; Robert C Bast
Journal:  Cell Adh Migr       Date:  2013-01-28       Impact factor: 3.405

7.  Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction.

Authors:  Shawna M Woollard; Biju Bhargavan; Fang Yu; Georgette D Kanmogne
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-26       Impact factor: 6.200

8.  Dual AAV/IL-10 Plus STAT3 Anti-Inflammatory Gene Delivery Lowers Atherosclerosis in LDLR KO Mice, but without Increased Benefit.

Authors:  Maohua Cao; Junaid A Khan; Bum-Yong Kang; Jawahar L Mehta; Paul L Hermonat
Journal:  Int J Vasc Med       Date:  2011-09-11

9.  Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with α5β1 integrin in glioma.

Authors:  D Kesanakurti; C Chetty; D H Dinh; M Gujrati; J S Rao
Journal:  Oncogene       Date:  2012-02-20       Impact factor: 9.867

10.  A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer.

Authors:  Wei Jia; Guang-He Fei; Jie-Gui Hu; Xian-Wei Hu
Journal:  Onco Targets Ther       Date:  2015-09-23       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.